Continued to make progress on the INPEFA launch, with third-quarter net sales of $1.7 million and market access discussions ongoing. Experienced growth in demand with an increase of 18 percent in ...

- Patients on acoramidis, a near complete (≥90%) TTR stabilizer in clinical development, lived longer and better as shown in ...

While diet is a fundamental tool for the management of KSD, individual-tailored dietary suggestions and maintaining adequate fluid intake are crucial for the prevention of kidney stones.